Artículo

Bisphosphonate-associated jaw osteonecrosis. Clinical case presentation

Velázquez Serrano, Sayra Nayelli; Fernández López, Rocío Gloria; Arellano Flores, Águeda

Facultad de Odontología, UNAM, publicado en Revista Odontológica Mexicana y cosechado de y cosechado de Revistas UNAM

Licencia de uso

La titularidad de los derechos patrimoniales de esta obra pertenece a las instituciones editoras. Su uso se rige por una licencia Creative Commons BY-NC-ND 4.0 Internacional, https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.es, fecha de asignación de la licencia 2013-04-17, para un uso diferente consultar al responsable jurídico del repositorio por medio de danyelacarmona@gmail.com. Ver términos de la licencia

Procedencia del contenido

Entidad o dependencia
Facultad de Odontología, UNAM
Revista
Repositorio
Contacto
Revistas UNAM. Dirección General de Publicaciones y Fomento Editorial, UNAM en revistas@unam.mx

Cita

Velázquez Serrano, Sayra Nayelli, et al. (2013). Bisphosphonate-associated jaw osteonecrosis. Clinical case presentation. Revista Odontológica Mexicana; Vol 17, No 1-ING. Recuperado de https://repositorio.unam.mx/contenidos/43137

Descripción del recurso

Autor(es)
Velázquez Serrano, Sayra Nayelli; Fernández López, Rocío Gloria; Arellano Flores, Águeda
Tipo
Artículo Técnico-Profesional
Área del conocimiento
Medicina y Ciencias de la Salud
Título
Bisphosphonate-associated jaw osteonecrosis. Clinical case presentation
Fecha
2013-04-17
Resumen
The aim of the present paper was to present the associationbetween mandibular osteonecrosis and use of bisphosphonatesfor therapeutic purposes. Bisphosphonates are drugs used forthe treatment of primary and secondary bone disorders. They aremainly used for local and general osteoporosis treatment, metabolicbone diseases, soft tissue calcifi cation as well as hypercalcemiaoccurrence, among others. They can also act as antineoplasticagents through the inhibition of activation of cancer-linked proteins.In recent years, bisphosphonates have been used to prevent postmenopausaeosteoporosis, since they enhance mineral densityincrease in bone and therefore contribute to a decrease in fractures.The clinical case here presented is that of a 61 year old femalepatient with previous history of breast cancer and ongoing 3 yearbisphosphonate intake. The patient presented asymptomatic,spontaneous bone exposition. Surgical and medical handlings of thecase are presented, as well as its evolution.
Idioma
eng
ISSN
ISSN: 1870-199X

Enlaces